Cancer Genomics

Cancer genomics focuses on understanding the genetic alterations that drive the development, progression, and treatment resistance of various cancers. By analyzing mutations, chromosomal rearrangements, gene amplifications, and epigenetic changes, researchers can identify the molecular mechanisms that transform normal cells into malignant ones. This knowledge enables the classification of tumors based on their genomic profiles, rather than solely on tissue origin, allowing for more accurate diagnosis and prognosis. Cancer genomics plays a crucial role in discovering targeted therapies and developing personalized treatment plans, as specific mutations can predict how a tumor will respond to particular drugs. Liquid biopsies and next-generation sequencing have improved early detection and real-time monitoring of tumor evolution. Overall, cancer genomics enhances precision oncology by guiding therapeutic choices, reducing overtreatment, and improving patient outcomes through deeper molecular insights.

×

Contact Emails

genomics@confmeets.net
support@confmeets.com
finance@confmeets.com

Article Processing Timeline

2-5 Days Initial Quality & Plagiarism Check
15
Days
Peer Review Feedback
85% Acceptance Rate (after peer review)
30-45 Days Total article processing time

Indexed In

Google Scholar
ResearchBib
Sindexs
OAJI
DOAJ
CrossRef
PubMed
MEDLINE
EBSCO A-Z / Host
OCLC - WorldCat

Journal Flyer

Flyer Image